Figure 2.
Concentration time curves for (a) IV decitabine vs oral C-DEC and (b) SQ azacitidine vs CC-486.40,46 Figure 2a was reproduced from Future Oncol. 2021;17(16):2077-2087 and was modified only by renumbering for the purpose of this article. Figure 2b was reproduced from Leukemia 2016;30(4):889-896 and was also modified only by renumbering. Both works are licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. http://creativecommons.org/licenses/by-nc-nd/4.0/